Coca-Cola: Chief Operating Officer Named New CEO; Exemplary Capital Allocation Rating Intact
We think Coca-Cola stock is fairly valued.

Key Morningstar Metrics for Coca-Cola
- Fair Value Estimate: $74
- Morningstar Rating: ★★★
- Morningstar Economic Moat Rating: Wide
- Morningstar Uncertainty Rating: Low
On Dec. 10, Coca-Cola KO named Chief Operating Officer Henrique Braun, a 30-year company veteran, as its next chief executive officer effective March 2026. He held senior executive roles overseeing international operations over the past decade. James Quincey will stay on as executive chairman.
Why it matters: We expect Braun to maintain the firm’s growth strategies underpinned by product innovation, consumer engagement, and agile in-market execution. He should be able to leverage his experiences in Latin America and Asia to unlock growth opportunities in the coming years.
- We expect Braun to prioritize organic sales growth led by health-focused innovation and closer bottler partnerships globally. After Quincey’s success in adding 10 billion-dollar brands during his nine-year tenure, acquisitions will likely remain a focus for Braun as well.
- Our Exemplary Capital Allocation Rating is intact following the CEO news, as we anticipate no change to Coke’s investment discipline. We expect the firm to maintain a strong balance sheet and allocate capital prudently to fuel growth while returning excess cash to shareholders.
The bottom line: We plan to maintain our $74 per share fair value estimate for wide-moat Coca-Cola. After rising 14% year to date, shares look fairly valued.
- We hold our 10-year forecasts of mid-single-digit organic sales growth on a balanced blend of price increases and volume expansion and adjusted operating margins averaging 31%.
- Braun will not need to spend much time on refranchising, as Coke is on track to bring sales contribution from bottling to 5% in 2026 from over 30% a decade ago. Instead, we expect him to apply his expertise in supply chain and bottler alliances to drive efficiency gains.
Editor’s Note: This analysis was originally published as a stock note by Morningstar Equity Research.
The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar’s editorial policies.
